These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
269 related articles for article (PubMed ID: 3002327)
1. Inhibition of platelet-activating-factor-induced human platelet activation by prostaglandin D2. Differential sensitivity of platelet transduction processes and functional responses to inhibition by cyclic AMP. Bushfield M; McNicol A; MacIntyre DE Biochem J; 1985 Nov; 232(1):267-71. PubMed ID: 3002327 [TBL] [Abstract][Full Text] [Related]
2. Octimibate, a potent non-prostanoid inhibitor of platelet aggregation, acts via the prostacyclin receptor. Merritt JE; Hallam TJ; Brown AM; Boyfield I; Cooper DG; Hickey DM; Jaxa-Chamiec AA; Kaumann AJ; Keen M; Kelly E Br J Pharmacol; 1991 Jan; 102(1):251-9. PubMed ID: 1710526 [TBL] [Abstract][Full Text] [Related]
4. Effects of activation of protein kinase C on the agonist-induced stimulation and inhibition of cyclic AMP formation in intact human platelets. Williams KA; Murphy W; Haslam RJ Biochem J; 1987 May; 243(3):667-78. PubMed ID: 2444206 [TBL] [Abstract][Full Text] [Related]
5. Regulation of platelet cytosolic free calcium by cyclic nucleotides and protein kinase C. MacIntyre DE; Bushfield M; Shaw AM FEBS Lett; 1985 Sep; 188(2):383-8. PubMed ID: 2993027 [TBL] [Abstract][Full Text] [Related]
6. Differential effects of 12-O-tetradecanoylphorbol 13-acetate on platelet responses to various agonists in the presence and absence of extracellular Ca2+. Powling MJ; Hardisty RM Thromb Res; 1986 Oct; 44(2):185-95. PubMed ID: 3787566 [TBL] [Abstract][Full Text] [Related]
7. Inhibition by forskolin of cytosolic calcium rise, shape change and aggregation in quin2-loaded human platelets. Sage SO; Rink TJ FEBS Lett; 1985 Aug; 188(1):135-40. PubMed ID: 2410292 [TBL] [Abstract][Full Text] [Related]
8. Desensitization and antagonism of vasopressin-induced phosphoinositide metabolism and elevation of cytosolic free calcium concentration in human platelets. Pollock WK; MacIntyre DE Biochem J; 1986 Feb; 234(1):67-73. PubMed ID: 3010956 [TBL] [Abstract][Full Text] [Related]
9. Molecular basis of the synergistic inhibition of platelet function by nitrovasodilators and activators of adenylate cyclase: inhibition of cyclic AMP breakdown by cyclic GMP. Maurice DH; Haslam RJ Mol Pharmacol; 1990 May; 37(5):671-81. PubMed ID: 2160060 [TBL] [Abstract][Full Text] [Related]
10. Dicentrine, a novel antiplatelet agent inhibiting thromboxane formation and increasing the cyclic AMP level of rabbit platelets. Yu SM; Chen CC; Ko FN; Huang YL; Huang TF; Teng CM Biochem Pharmacol; 1992 Jan; 43(2):323-9. PubMed ID: 1310852 [TBL] [Abstract][Full Text] [Related]
11. Dual effects of oleic acid on Ca2+ mobilization and protein phosphorylation in human platelets in presence or absence of platelet activating factor. Kimoto M; Javors MA; Ekholm J; Siafaka-Kapadai A; Hanahan DJ Arch Biochem Biophys; 1992 Nov; 298(2):471-9. PubMed ID: 1384432 [TBL] [Abstract][Full Text] [Related]
12. Receptor-effector coupling in platelets: roles of guanine nucleotides. Haslam RJ; Williams KA; Davidson MM Adv Exp Med Biol; 1985; 192():265-80. PubMed ID: 3010668 [TBL] [Abstract][Full Text] [Related]
13. Thromboxane-induced phosphatidate formation in human platelets. Relationship to receptor occupancy and to changes in cytosolic free calcium. Pollock WK; Armstrong RA; Brydon LJ; Jones RL; MacIntyre DE Biochem J; 1984 May; 219(3):833-42. PubMed ID: 6234886 [TBL] [Abstract][Full Text] [Related]
14. Inhibition of human platelets and polymorphonuclear neutrophils by the potent and metabolically stable prostaglandin D2 analog ZK 118.182. Darius H; Michael-Hepp J; Thierauch KH; Fisch A Eur J Pharmacol; 1994 Jun; 258(3):207-13. PubMed ID: 7522176 [TBL] [Abstract][Full Text] [Related]
15. Cyclic AMP does not inhibit collagen-induced platelet signal transduction. Smith JB; Dangelmaier C; Selak MA; Ashby B; Daniel J Biochem J; 1992 May; 283 ( Pt 3)(Pt 3):889-92. PubMed ID: 1375452 [TBL] [Abstract][Full Text] [Related]
16. Lag-phase of arachidonic acid-induced secretion in responders and non-responders to the thromboxane-synthetase inhibitors: involvement of cyclic-AMP. Lecompte T; Joussemet M; Hainaut J Thromb Res; 1984 Jul; 35(1):91-7. PubMed ID: 6089368 [No Abstract] [Full Text] [Related]
17. Forskolin and prostacyclin inhibit fluoride induced platelet activation and protein kinase C dependent responses. Doni MG; Deana R; Bertoncello S; Zoccarato F; Alexandre A Biochem Biophys Res Commun; 1988 Nov; 156(3):1316-23. PubMed ID: 2847730 [TBL] [Abstract][Full Text] [Related]
18. Interrelation of prostaglandin endoperoxide (prostaglandin G2) and cyclic 3',5'-adenosine monophosphate in human blood platelets. Salzman EW Biochim Biophys Acta; 1977 Aug; 499(1):48-60. PubMed ID: 196670 [TBL] [Abstract][Full Text] [Related]
19. Inhibition of adenylate cyclase by adenosine analogues in preparations of broken and intact human platelets. Evidence for the unidirectional control of platelet function by cyclic AMP. Haslam RJ; Davidson MM; Desjardins JV Biochem J; 1978 Oct; 176(1):83-95. PubMed ID: 215136 [TBL] [Abstract][Full Text] [Related]
20. Translocation-independent activation of protein kinase C by platelet-activating factor, thrombin and prostacyclin. Lack of correlation with polyphosphoinositide hydrolysis in rabbit platelets. Salari H; Duronio V; Howard S; Demos M; Pelech SL Biochem J; 1990 May; 267(3):689-96. PubMed ID: 2160234 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]